| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.005 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.006 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.007 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |